Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Gross Profit Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual gross profit in 2023 was 4.39 Billion CNY , up 39.84% from previous year.
Innovent Biologics, Inc.'s latest quarterly gross profit in 2024 Q2 was 1.42 Billion CNY , down 0.0% from previous quarter.
Innovent Biologics, Inc. reported a annual gross profit of 3.62 Billion CNY in annual gross profit 2022, down -1.93% from previous year.
Innovent Biologics, Inc. reported a annual gross profit of 3.69 Billion CNY in annual gross profit 2021, up 6.96% from previous year.
Innovent Biologics, Inc. reported a quarterly gross profit of 1.42 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Innovent Biologics, Inc. reported a quarterly gross profit of 1.23 Billion CNY for 2023 Q3, up 29.15% from previous quarter.

Annual Gross Profit Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Gross Profit of Innovent Biologics, Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	4.39 Billion CNY	39.84%
2022	3.62 Billion CNY	-1.93%
2021	3.69 Billion CNY	6.96%
2020	3.45 Billion CNY	274.58%
2019	922.64 Million CNY	8451.96%
2018	10.78 Million CNY	-88.01%
2017	90 Million CNY	180.17%
2016	32.12 Million CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	1.42 Billion CNY	15.26%
2024 Q2	1.42 Billion CNY	0.0%
2023 Q3	1.23 Billion CNY	29.15%
2023 Q1	959.88 Million CNY	16.82%
2023 Q2	959.88 Million CNY	0.0%
2023 Q4	1.23 Billion CNY	0.0%
2023 FY	5.06 Billion CNY	39.84%
2022 Q2	765.61 Million CNY	0.0%
2022 Q4	821.7 Million CNY	0.0%
2022 FY	3.62 Billion CNY	-1.93%
2022 Q3	821.7 Million CNY	7.33%
2022 Q1	765.61 Million CNY	-7.77%
2021 Q4	830.12 Million CNY	0.0%
2021 Q3	830.12 Million CNY	19.87%
2021 Q2	692.53 Million CNY	0.0%
2021 Q1	692.53 Million CNY	-42.47%
2021 FY	3.69 Billion CNY	6.96%
2020 FY	3.45 Billion CNY	274.58%
2020 Q4	1.2 Billion CNY	0.0%
2020 Q3	1.2 Billion CNY	262.34%
2020 Q2	332.22 Million CNY	0.0%
2020 Q1	332.22 Million CNY	406.23%
2019 FY	922.64 Million CNY	8451.96%
2019 Q1	145.83 Million CNY	5685.92%
2019 Q3	65.62 Million CNY	-55.0%
2019 Q4	65.62 Million CNY	0.0%
2019 Q2	145.83 Million CNY	0.0%
2018 Q1	2.21 Million CNY	-93.1%
2018 Q4	2.52 Million CNY	0.0%
2018 Q3	2.52 Million CNY	13.64%
2018 Q2	2.21 Million CNY	0.0%
2018 FY	10.78 Million CNY	-88.01%
2017 Q1	5.33 Million CNY	0.0%
2017 FY	90 Million CNY	180.17%
2017 Q4	32.15 Million CNY	0.0%
2017 Q3	32.15 Million CNY	503.14%
2017 Q2	5.33 Million CNY	0.0%
2016 FY	32.12 Million CNY	0.0%

Peer Gross Profit Comparison of Innovent Biologics, Inc.

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	-1019.915%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	-364.197%